MA47730A - Inhibiteurs de bêta-sécrétase - Google Patents
Inhibiteurs de bêta-sécrétaseInfo
- Publication number
- MA47730A MA47730A MA047730A MA47730A MA47730A MA 47730 A MA47730 A MA 47730A MA 047730 A MA047730 A MA 047730A MA 47730 A MA47730 A MA 47730A MA 47730 A MA47730 A MA 47730A
- Authority
- MA
- Morocco
- Prior art keywords
- beta
- secretase inhibitors
- secretase
- inhibitors
- Prior art date
Links
- 239000002439 beta secretase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762467998P | 2017-03-07 | 2017-03-07 | |
| EP17189756 | 2017-09-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA47730A true MA47730A (fr) | 2020-01-15 |
Family
ID=61616994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA047730A MA47730A (fr) | 2017-03-07 | 2018-03-06 | Inhibiteurs de bêta-sécrétase |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210284659A1 (fr) |
| EP (1) | EP3592751A1 (fr) |
| JP (1) | JP2020509074A (fr) |
| KR (1) | KR20190126828A (fr) |
| CN (1) | CN110382507A (fr) |
| AU (1) | AU2018229722A1 (fr) |
| CA (1) | CA3051373A1 (fr) |
| MA (1) | MA47730A (fr) |
| MX (1) | MX2019010659A (fr) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR077277A1 (es) * | 2009-07-09 | 2011-08-17 | Lilly Co Eli | Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer |
| US20120245155A1 (en) * | 2009-12-11 | 2012-09-27 | Shionogi & Co., Ltd. | Fused heterocyclic compound having amino group |
-
2018
- 2018-03-06 MX MX2019010659A patent/MX2019010659A/es unknown
- 2018-03-06 US US16/489,856 patent/US20210284659A1/en not_active Abandoned
- 2018-03-06 MA MA047730A patent/MA47730A/fr unknown
- 2018-03-06 CA CA3051373A patent/CA3051373A1/fr not_active Abandoned
- 2018-03-06 KR KR1020197028605A patent/KR20190126828A/ko not_active Withdrawn
- 2018-03-06 EP EP18710000.3A patent/EP3592751A1/fr not_active Withdrawn
- 2018-03-06 CN CN201880016452.5A patent/CN110382507A/zh active Pending
- 2018-03-06 JP JP2019548669A patent/JP2020509074A/ja active Pending
- 2018-03-06 AU AU2018229722A patent/AU2018229722A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2019010659A (es) | 2019-10-21 |
| AU2018229722A1 (en) | 2019-08-08 |
| CN110382507A (zh) | 2019-10-25 |
| JP2020509074A (ja) | 2020-03-26 |
| EP3592751A1 (fr) | 2020-01-15 |
| CA3051373A1 (fr) | 2018-09-13 |
| US20210284659A1 (en) | 2021-09-16 |
| KR20190126828A (ko) | 2019-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283639A (en) | Kif18a inhibitors | |
| MA54550A (fr) | Inhibiteurs de kif18a | |
| IL269196A (en) | Novel inhibitors | |
| EP3541932A4 (fr) | Inhibiteurs de crispr-cas9 | |
| DK3612525T3 (da) | Pd-1-/pd-l1-inhibitorer | |
| EP3801503A4 (fr) | Inhibiteurs de sarm1 | |
| DK3497103T3 (da) | Pyridopyrimdinon-cdk2/4/6-inhibitorer | |
| DK3571192T3 (da) | Jak1-selektive inhibitorer | |
| DK3442972T3 (da) | Bromdomænehæmmere | |
| EP3347008A4 (fr) | Inhibiteurs de bêta-lactamases | |
| LT3303334T (lt) | Tirozinkinazės inhibitoriai | |
| DK3681884T3 (da) | Rad51-inhibitorer | |
| EP3541820A4 (fr) | Inhibiteurs de magl | |
| EP3313828A4 (fr) | Inhibiteurs de métallo-bêta-lactamases | |
| CU20160125A7 (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
| MA52813A (fr) | Inhibiteurs de sarm1 | |
| MA46857A (fr) | Inhibiteurs de magl | |
| EP3817736A4 (fr) | Inhibiteurs de pikfyve | |
| MA46860A (fr) | Inhibiteurs de magl | |
| EP3609882A4 (fr) | Inhibiteurs hétérocycliques de pcsk9 | |
| MA52809A (fr) | Inhibiteurs de sarm1 | |
| DK3630744T3 (da) | Pyrazol-magl-inhibitorer | |
| EP3720436A4 (fr) | Inhibiteurs de tubuline | |
| MA43367A (fr) | Inhibiteurs de métallo-bêta-lactamases | |
| EP3600301A4 (fr) | Inhibiteurs de kdm4 |